Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.18 | -10.843373494 | 1.66 | 1.7 | 1.47 | 2168306 | 1.56462018 | CS |
| 4 | -1.71 | -53.605015674 | 3.19 | 3.46 | 1.26 | 3605723 | 1.71046488 | CS |
| 12 | -11.83 | -88.8805409467 | 13.31 | 13.71 | 1.26 | 2733640 | 3.21206482 | CS |
| 26 | -10.02 | -87.1304347826 | 11.5 | 16.1 | 1.26 | 1502937 | 5.07056143 | CS |
| 52 | -13.05 | -89.8141775637 | 14.53 | 16.52 | 1.26 | 979239 | 6.93809329 | CS |
| 156 | -6.02 | -80.2666666667 | 7.5 | 36.64 | 1.26 | 829658 | 15.4082662 | CS |
| 260 | -21.02 | -93.4222222222 | 22.5 | 43.92 | 1.26 | 562966 | 16.15394357 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
